JNE Partners LLP - Q4 2020 holdings

$81.5 Million is the total value of JNE Partners LLP's 4 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was 33.3% .

 Value Shares↓ Weighting
UHAL  AMERCO$32,606,000
+27.5%
71,8260.0%39.99%
+79.2%
NG SellNOVAGOLD RES INC$18,905,000
-25.5%
1,955,047
-8.5%
23.19%
+4.6%
CMCSA  COMCAST CORP NEWcl a$18,754,000
+13.3%
357,9020.0%23.00%
+59.2%
SCHW SellSCHWAB CHARLES CORP$11,271,000
-44.5%
212,500
-62.1%
13.82%
-22.1%
COTY ExitCOTY INC$0-2,694,732
-100.0%
-6.35%
HST ExitHOST HOTELS & RESORTS INC$0-1,802,200
-100.0%
-16.97%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-02-17
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
NOVAGOLD RES INC16Q3 202334.9%
AMERCO11Q3 202240.0%
ELLIOTT OPPORTUNITY II CORP9Q2 202319.8%
COMCAST CORP NEW8Q1 202223.5%
ORION BIOTECH OPPORTUNTES CO8Q1 202311.1%
MSD ACQUISITION CORP8Q4 202211.1%
LIBERTY MEDIA CORP DEL8Q2 202313.9%
ROCKET INTERNET GRWT OPRT CO8Q4 20223.2%
KKR ACQUISITION HOLDING I CO7Q3 20221.7%
MICRON TECHNOLOGY INC5Q3 202356.9%

View JNE Partners LLP's complete holdings history.

Latest significant ownerships (13-D/G)
JNE Partners LLP Q4 2020 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Prevail Therapeutics Inc.January 29, 2021? ?

View JNE Partners LLP's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-15
13F-HR2022-05-16
13F-HR2022-02-15
13F-HR2021-11-15

View JNE Partners LLP's complete filings history.

Compare quarters

Export JNE Partners LLP's holdings